Ornithine carbamoyltransferase deficiency
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
HMT delivery of human OTC mRNA normalizes plasma ammonia and urinary orotic acid levels, and leads to a prolonged survival benefit in the murine OTCD model.
|
29433939 |
2018 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Mutations occurring close to the catalytic site of OTCase can cause severe OTCD phenotypes compared with those caused by mutations occurring on the surface of this protein.
|
30175132 |
2018 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
About 10%-15% of patients, clinically diagnosed with OTC deficiency (OTCD), lack identifiable mutations in the coding region or splice junctions of the OTC gene on routine molecular testing.
|
29282796 |
2018 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Ornithine transcarbamylase deficiency (OTCD) is an X-linked recessive disorder involving a defect in the urea cycle caused by OTC gene mutations.
|
30541480 |
2018 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Gene Mutation Analysis and Prenatal Diagnosis of the Ornithine Transcarbamylase (OTC) Gene in Two Families with Ornithine Transcarbamylase Deficiency.
|
30333473 |
2018 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Clinical and mutation analysis of 24 Chinese patients with ornithine transcarbamylase deficiency.
|
28266016 |
2017 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
Biomarker
|
disease |
BEFREE |
AAV gene therapy corrects OTC deficiency and prevents liver fibrosis in aged OTC-knock out heterozygous mice.
|
28283349 |
2017 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
LC-MS/MS assay of plasma OTC activity enabled the detection of all hemizygous and the majority of symptomatic heterozygous OTCD patients in the tested cohort.
|
28107167 |
2017 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Frequency and Pathophysiology of Acute Liver Failure in Ornithine Transcarbamylase Deficiency (OTCD).
|
27070778 |
2016 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
Biomarker
|
disease |
MGD |
A new mouse model of mild ornithine transcarbamylase deficiency (spf-j) displays cerebral amino acid perturbations at baseline and upon systemic immune activation.
|
25647322 |
2015 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Clinical outcomes and the mutation spectrum of the OTC gene in patients with ornithine transcarbamylase deficiency.
|
25994866 |
2015 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
This novel mutation in the OTC gene is responsible for the late-onset phenotype of OTC deficiency.
|
26446336 |
2015 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
Clinical outcomes and the mutation spectrum of the OTC gene in patients with ornithine transcarbamylase deficiency.
|
25994866 |
2015 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Clinical outcomes and the mutation spectrum of the OTC gene in patients with ornithine transcarbamylase deficiency.
|
25994866 |
2015 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
Biomarker
|
disease |
CLINGEN |
Genotype-Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation Update.
|
26059767 |
2015 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The aim of this study was to provide clues for recognition of OTCD in adults and analyze the environmental factors that, interacting with OTC gene mutations, might have triggered acute clinical manifestations.
|
25026867 |
2014 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
Biomarker
|
disease |
CLINGEN |
Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics.
|
24309898 |
2014 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
Biomarker
|
disease |
BEFREE |
OTC gene in ornithine transcarbamylase deficiency: clinical course and mutational spectrum in seven Korean patients.
|
25011434 |
2014 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Urea cycle disorders in Spain: an observational, cross-sectional and multicentric study of 104 cases.
|
25433810 |
2014 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Sudden unexpected fatal encephalopathy in adults with OTC gene mutations-Clues for early diagnosis and timely treatment.
|
25026867 |
2014 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Magnetic resonance spectroscopy and molecular studies in ornithine transcarbamylase deficiency novel mutation c.802A>G in exon 8 (p.Met268Val).
|
23821427 |
2013 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
A case with combined rare inborn metabolic disorders: congenital adrenal hyperplasia and ornithine transcarbamylase deficiency.
|
23769969 |
2013 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A 66-year-old woman heterozygous for a mutation in the ornithine transcarbamylase gene (Otc) participated in a phase I gene therapy trial for OTC deficiency.
|
24010702 |
2013 |
Ornithine carbamoyltransferase deficiency
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
Coagulopathy in patients with late-onset ornithine transcarbamylase deficiency in remission state: a previously unrecognized complication.
|
23209112 |
2013 |